Abstract
In February 2016, the National Institute for Health and Care Excellence (NICE) published guidelines on multiple myeloma. NICE have published numerous guidelines relating to haematology, but this was the first guideline focusing on a single haematological malignancy. The purpose of this review was to highlight the recommendations made in the guideline and the implications for the management of patients in the UK and also internationally. In addition, we review the NICE process and highlight issues around current guideline development.
| Original language | English |
|---|---|
| Pages (from-to) | 3-13 |
| Number of pages | 11 |
| Journal | International Journal of Laboratory Hematology |
| Volume | 39 |
| Issue number | 1 |
| Early online date | 20 Dec 2016 |
| DOIs | |
| Publication status | Published - Feb 2017 |
Keywords
- Multiple Myeloma/diagnosis
- National Institutes of Health (U.S.)
- Practice Guidelines as Topic
- United Kingdom
- United States